News alert: Despite a lack of research to back up the move, the FDA has authorized wider use of the drug remdesivir as a COVID-19 treatment

Late Friday afternoon, the FDA said it would allow remdesivir to be used on all patients hospitalized with COVID-19, not just those on oxygen. But no research has been published that supports widespread use. It is the second time in a week the FDA has authorized wider use of a COVID-19 treatment without the science to support such a move. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
usatoday.com

News Alert
 
Friday, August 28
Despite a lack of research to back up the move, the FDA has authorized wider use of the drug remdesivir as a COVID-19 treatment
Late Friday afternoon, the FDA said it would allow remdesivir to be used on all patients hospitalized with COVID-19, not just those on oxygen. But no research has been published that supports widespread use. It is the second time in a week the FDA has authorized wider use of a COVID-19 treatment without the science to support such a move.
Read More
 
FOLLOW US
FB TW IG

Problem viewing email? View in browser

Unsubscribe Manage Newsletters Terms of Service Privacy Policy/Your California Privacy Rights Privacy Notice Do Not Sell My Info/Cookie Policy Feedback

Comments

Popular Posts

Fwd: Claim "Climate law & governance" for your profile

Commissions Successfully

We have Your e-Wallet ready. Claim in 3hrs

Beneficiary countersignature modification

The State Department requires proof that you are the owner.

Your order requires immediate confirmation.

January 3nd Nоte (Оpen Up)

You’re four weeks away from more followers 📱

Reduced Payment!.